Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.20.1
STOCKHOLDERS' EQUITY (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2018
Jan. 31, 2020
Dec. 31, 2019
Sep. 28, 2018
STOCKHOLDERS' EQUITY (Details) [Line Items]          
Preferred stock, authorized 10,000,000     10,000,000  
Preferred stock, par value (in Dollars per share) $ 0.0001     $ 0.0001  
Common stock, authorized 350,000,000     350,000,000  
Common stock, par value (in Dollars per share) $ 0.0001     $ 0.0001 $ 0.0001
Common stock, issued 59,268,085     59,268,085  
Common stock, outstanding 59,268,085     59,268,085  
Common stock reserved for issuance 10,000,000        
Stock options to purchase     19,625    
Weighted-average contractual remaining life 4 years 6 months        
Restricted Stock Units (RSUs) [Member]          
STOCKHOLDERS' EQUITY (Details) [Line Items]          
Stock compensation expense (in Dollars) $ 10,120        
Restricted stock purchase   378,478      
Non vested restricted shares 94,620        
Weighted average grant-date fair value (in Dollars per share) $ 0.22        
Vesting period 2 years        
Unrecognized compensation expense related to the unvested portion of RSU (in Dollars) $ 20,237        
Expected weighted average vesting period 6 months        
Stock Options [Member]          
STOCKHOLDERS' EQUITY (Details) [Line Items]          
Stock options to purchase 694,625        
Stock compensation expense (in Dollars) $ 15,479        
Stock option exercise price, decrease (in Dollars per share) $ 2.50        
Stock option exercise price, increase (in Dollars per share) 3.25        
Weighted average exercise price (in Dollars per share) $ 3.23        
Warrants [Member]          
STOCKHOLDERS' EQUITY (Details) [Line Items]          
Warrants outstanding 4,771,417        
Weighted-average contractual remaining life 2 years 219 days        
Exercise prices decrease (in Dollars per share) $ 0.01        
Exercise prices increase (in Dollars per share) 3.25        
Weighted average exercise price (in Dollars per share) $ 3.15